Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of California, 4150 V Street, Suite 3400, Davis, CA, USA.
Drugs Aging. 2013 Jul;30(7):479-502. doi: 10.1007/s40266-013-0080-1.
The elderly patient (65 years and older) with chronic obstructive pulmonary disease (COPD) can be a challenge to the clinician. This begins with the correct and early diagnosis, the assessment of disease severity, recognizing complicating comorbidities, determining the burden of symptoms, and monitoring the frequency of acute exacerbations. Comprehensive management of COPD in the elderly patient should improve health-related quality of life, lung function, reduce exacerbations, and promote patient compliance with treatment plans. Only smoking cessation and oxygen therapy in COPD patients with hypoxemia reduce mortality. Bronchodilators, corticosteroids, methylxanthines, phosphodiesterase-4 inhibitors, macrolide antibiotics, mucolytics, and pulmonary rehabilitation improve some outcome measures such as spirometry measures and the frequency of COPD exacerbations without improving mortality. International treatment guidelines to reduce symptoms and reduce the risk of acute exacerbations exist. Relief of dyspnea and control of anxiety are important. The approach to each patient is best individualized. Earlier use of palliative care should be considered when traditional pharmacotherapy fails to achieve outcome measures and before consideration of end-of-life issues.
老年(65 岁及以上)慢性阻塞性肺疾病(COPD)患者对临床医生来说是一个挑战。这始于正确和早期的诊断、疾病严重程度的评估、识别合并症、确定症状负担以及监测急性加重的频率。对老年 COPD 患者进行全面管理应改善健康相关生活质量、肺功能、减少加重并促进患者对治疗计划的依从性。只有 COPD 合并低氧血症的患者戒烟和吸氧才能降低死亡率。支气管扩张剂、皮质类固醇、黄嘌呤类药物、磷酸二酯酶-4 抑制剂、大环内酯类抗生素、黏液溶解剂和肺康复可改善某些结局指标,如肺活量测量和 COPD 加重的频率,但不改善死亡率。存在减少症状和降低急性加重风险的国际治疗指南。缓解呼吸困难和控制焦虑很重要。最好对每位患者进行个体化治疗。当传统药物治疗无法实现治疗目标且在考虑临终问题之前,应更早地考虑姑息治疗。